Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Financial Flexibility Index

Latest as of December 2024: 1.26x

Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Financial Flexibility Index of 1.26x as of December 2024. Free cash flow of CN¥252.21 Million (operating CF CN¥122.51 Million minus capex CN¥129.71 Million) represents 1% of total liabilities (CN¥199.66 Million). Check 688273 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Financial Flexibility Index

1.26x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥252.21 Million
Operating CF − Capex

Total Liabilities

CN¥199.66 Million
CNY

Capital Expenditures

CN¥129.71 Million
CNY

Nanjing Medlander Medical Technology Co. Ltd. A Financial Flexibility Index (2020–2024)

Historical Financial Flexibility Index trend for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. See Nanjing Medlander Medical Technology Co. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)

Year-by-year free cash flow to debt coverage for Nanjing Medlander Medical Technology Co. Ltd. A. For the full company profile including market capitalisation, see how much is Nanjing Medlander Medical Technology Co. worth.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2024 1.26x CN¥252.21 Million CN¥122.51 Million CN¥199.66 Million ▼ -5.5%
2023 1.34x CN¥212.06 Million CN¥136.91 Million CN¥158.60 Million ▲ +4.9%
2022 1.27x CN¥180.93 Million CN¥126.67 Million CN¥141.96 Million ▼ -9.4%
2021 1.41x CN¥163.18 Million CN¥148.60 Million CN¥116.01 Million ▼ -20.5%
2020 1.77x CN¥157.01 Million CN¥131.10 Million CN¥88.69 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities